Stockreport

Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF High-throughput efficiency, with up to 2,000 tests per hour on cobas® c 703 and up to 70 reagent positions for testing optimization. The new cobas® ISE neo analytical [Read more]